Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Lobe Sciences Ltd
C.LOBE
Alternate Symbol(s):
LOBEF
Healthcare
Drug Manufacturers - Major
Lobe Sciences Ltd. is a Canada-based biopharmaceutical company focused on developing medicines to treat diseases with unmet medical needs. The Company, through collaborations with partners, is engaged in research and development focused on treating chronic cluster headache (an orphan disease), refractive anxiety, and sickle cell disease. In addition, the Company is commercializing Altemia, for...
the treatment of patients diagnosed with Sickle Cell Disease. The Company is engaged in Phase 1 and Phase 2 activities in its drug portfolios. Its subsidiaries include Eleusian Biosciences Corp., Lobe Sciences Australia Pty Ltd., and Altemia & Company, LLC.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:LOBE)
New Post
View:
Posts & Comments
Threaded Posts
(1)
•••
FratzyBottFish
X
Post by
FratzyBottFish
on Feb 28, 2025 9:10am
Raymond James add a few going to close
Yeap! Raymond James bought a 320K 5 min before close yestrd keeping an eye
(26)
•••
BullBuy
X
Post by
BullBuy
on Jun 04, 2024 5:47pm
Dormant stock getting ready for a comeback?
"As we review the psychedelic market, it is clear that L-130 is a differentiated compound with a very unique profile not seen in any other product. We will pursue every avenue to ensure our
...more
Expansion Through Strategic Partnerships & Offtake Agreements
posted Mar 18, 2025 9:00am by
ReGen III Corp.
-
|
By strategically aligning with key industry players, ReGen III is targeting sustainable, capital-efficient expansion, providing long-term revenue growth potential and competitive market leadership in the circular economy ...read more
(26)
•••
BullBuy
X
Comment by
BullBuy
on Jun 04, 2024 11:22am
RE:Looks like $LOBE has been busy in 2023
Volume has started ticking up with the recent announcements.
(15)
•••
AgileTrader
X
Post by
AgileTrader
on Feb 15, 2024 5:42pm
Looks like $LOBE has been busy in 2023
Year end financials are out and it looks like 2024 might be the year the stock runs thanks to Altemia, which is the company's first commercial product. It's a medical food for the management
...more
(2830)
•••
Betteryear2
X
Post by
Betteryear2
on May 17, 2023 5:20pm
Lobe Sciences Announces Commercial Distribution Agreement
May 17, 2023 08:45 AM Eastern Daylight Time VANCOUVER, British Columbia--(BUSINESS WIRE)--Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
Featured News Links
ReGen III: Transformative Clean Technology, Growing Demand, and Proven Leadership
Pinnacle Samples up to 12.2 g/t Gold Equivalent and Commences Field Work at El Potrero Gold-Silver Project